Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating cancer resistant to ErbB therapeutics

Methods for treating cancer resistant to ErbB therapeutics

US Patent 11008620 · Granted May 18, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CDCP1 antibodies and antibody drug conjugates2025
Pyrimidines as EGFR-inhibitors and methods of treating disorders2025
Combination therapy for PI3K-associated disease or disorder2025
Degraders that target ALK and therapeutic uses thereof2025
Pharmaceutical combination comprising an ALK inhibitor and a SHP2 inhibitor2024
Method to determine responsiveness of cancer to epidermal growth factor receptor2024
Inhibitors of EGFR and/or HER2 and methods of use2024
Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK2024
Targeting chromosomal instability and downstream cytosolic DNA signaling for can2023
Cyano quinoline amide compounds as HER2 inhibitors and methods of use2023
Pyrimidines as EGFR inhibitors and methods of treating disorders2023
Inhibitors of EGFR and methods of use thereof2023